|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||
| Prepaid Expenses | ||||||||
| Total Current Assets | ||||||||
| Intangible Asset, Net | ||||||||
| TOTAL ASSETS | ||||||||
| Accounts Payable | ||||||||
| Related Party Loan | ||||||||
| Total Current Liabilities | ||||||||
| Total Liabilities | ||||||||
| Common stock: $0.001 par value, 75,000,000 shares authorized, 5,317,706 and 5,317,706 shares issued and outstanding as of June 30, 2026, and March 31, 2026, respectively | ||||||||
| Additional Paid in Capital | ||||||||
| Accumulated Deficit | ||||||||
| Total Stockholders’ Equity | ||||||||
| TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY |
Loading...
